Review of U.S. Customs and Border Protection's Fiscal Year 2016 Drug Control Performance Summary Report

CBP’s management prepared the Performance Summary Report and the related disclosures in accordance with the requirements of the Office of National Drug Control Policy’s (ONDCP) Circular, Accounting of Drug Control Funding and Performance Summary, dated January 18, 2013.  Based on its review, nothing came to KPMG’s attention that caused it to believe that CBP’s FY 2016 Performance Summary Report is not presented in conformity with the criteria in ONDCP’s Circular.  KPMG did not make any recommendations as a result of its review.